TaperMeds — Deprescribing Software

Gabapentin Tapering Guide

gabapentin

GabapentinoidFDA 1993
Try TaperMeds

Boxed Warning

Respiratory depression risk when used with CNS depressants, particularly opioids. Increased risk of suicidal thoughts and behavior (anticonvulsant class warning).

Overview

Gabapentin is an anticonvulsant approved for epilepsy (adjunctive therapy for partial seizures) and postherpetic neuralgia. It is widely prescribed off-label for neuropathic pain, anxiety, insomnia, and alcohol/benzodiazepine withdrawal. Despite its name, it does not bind GABA receptors.

Common Doses

100mg, 300mg, 600mg, 800mg

Formulations

Capsules: 100mg, 300mg, 400mg; Tablets: 600mg, 800mg; Oral solution: 250mg/5mL; Extended-release tablets (Gralise): 300mg, 600mg

Pregnancy

Category C (risk cannot be ruled out)

Mechanism of Action

Binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing calcium influx and subsequent release of excitatory neurotransmitters (glutamate, norepinephrine, substance P). Does not bind GABA receptors or affect GABA uptake/metabolism.

Taper Notes

Short half-life (5–7 hours) with saturable, non-linear absorption (~60% bioavailability at 300 mg, ~35% at 1600 mg). Multiple daily doses required to maintain plasma levels. Water titration (capsule contents in suspension) supports precise reductions.

Maudsley Deprescribing Guidance

Apply ~10% proportional reductions per step. Non-linear absorption means absolute mg reductions at high doses produce smaller plasma changes than at low doses — adjust step size accordingly. Aqueous suspension via opened capsules supports fine titration.

Common Withdrawal Symptoms

anxietyinsomnianauseasweatingseizure risk at high dosespain rebound

Interactions & Safety

Drug Interactions

  • Opioids — increased risk of respiratory depression and sedation
  • CNS depressants — additive sedation
  • Antacids containing aluminum/magnesium reduce gabapentin absorption by ~20% — dose gabapentin ≥2 hours after antacids

Food Interactions

  • Food modestly increases absorption (~14%)
  • Avoid alcohol (additive CNS depression)

Contraindications

  • Known hypersensitivity to gabapentin

Toxicity

Relatively low acute toxicity. Respiratory depression when combined with opioids or CNS depressants. Suicidal ideation (class warning for anticonvulsants). Physical dependence with chronic high-dose use.

Pharmacokinetics

ADME Profile

Absorption

Absorbed via L-amino acid transport system in the small intestine. Bioavailability is dose-dependent (inversely proportional): ~60% at 300mg, ~35% at 1600mg. Tmax 2–3 hours. Food modestly increases absorption.

Distribution

~0.8 L/kg (58 L in 72 kg individual)

Metabolism

Not appreciably metabolized in humans. No CYP involvement. Excreted unchanged.

Elimination

Renal (~100% excreted unchanged). Clearance is proportional to creatinine clearance.

Protein Binding

<3% (not significantly protein bound)

Clearance

~120–130 mL/min (renal clearance, similar to GFR)

Build Gabapentin taper plans in minutes

TaperMeds turns these protocols into prescriber-ready taper schedules with hyperbolic dose curves, symptom tracking, and patient handouts — for the clinicians supervising the taper.

Try TaperMeds

Other Medication Profiles

Book a Free Demo